Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders

 
 

VERTEX PHARMACEUTICALS INC / MA (VRTX) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $222.53 Metrics
OS: 256.5 M
Market cap: $57.1 B
Net cash: $11.5 B $44.82 per share
EV: $45.6 B

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
Revenues8,930.77,574.46,205.74,162.83,047.62,488.71,702.21,032.3
            Revenue growth17.9%22.1%49.1%36.6%22.5%46.2%64.9%77.9%
Cost of goods sold1,080.3904.2736.3547.8409.5275.1210.5117.2
Gross profit7,850.46,670.25,469.43,615.02,638.12,213.51,491.7915.2
            Gross margin87.9%88.1%88.1%86.8%86.6%88.9%87.6%88.7%
Selling, general and administrative944.7840.1770.5658.5557.6496.1432.8376.6
Research and development2,540.33,051.11,829.51,754.51,416.51,324.61,047.7995.9
EBIT4,365.42,779.02,869.41,202.0664.0392.811.2-464.7
            EBIT margin48.9%36.7%46.2%28.9%21.8%15.8%0.7%-45.0%
Pre-tax income4,232.42,730.43,116.91,394.9600.2-15.7-67.4-557.8
Income taxes910.4388.3405.2218.1-1,486.9-107.316.730.4
            Tax rate21.5%14.2%13.0%15.6% 684.1%  
Net income3,322.02,342.12,711.71,176.82,096.9263.5-112.1-556.3
            Net margin37.2%30.9%43.7%28.3%68.8%10.6%-6.6%-53.9%
 
Diluted EPS$12.82$9.01$10.29$4.51$8.09$1.04($0.46)($2.31)
Shares outstanding (diluted)259.1259.9263.4260.7259.2253.2244.7241.3
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy